NeoGenomics Laboratories, Inc.

NEO US Health Care Health Care Services
S&P 600
$17.32
-1.65%
Delayed · cached 15 min
Fair Value Analysis →

Price Chart

Price50-day avg200-day avg

How to read this: the line is the closing price over time. The two dashed lines are moving averages — the average price over the last 50 and 200 trading days — which smooth out daily noise to show the broader trend. Price above its moving averages reflects recent strength; below reflects recent weakness. Use the buttons to change the time range. Prices are end-of-day, not live.

Strengths

  • Low debt: debt-to-equity of 0.44.
  • Current assets comfortably cover current liabilities (current ratio 4.26).

!Watch-points

  • Thin interest cover: operating profit covers interest only about -30.9 times.
  • Return on equity is on the lower side at -13.8%.
  • Return on capital employed is on the lower side at -9.2%.
  • The company reported a net loss in the latest period.

These points are generated automatically from the company’s reported figures to highlight what stands out. They are descriptive observations for educational purposes only — not advice or a recommendation to buy, sell, or hold.

Forensic Checks

Altman Z-ScoreDistress zone
0.06

In Altman’s study, scores in this range were associated with a higher incidence of financial distress.

Computed without the market-value term.

Piotroski F-ScoreModerate
4 / 8

The F-Score adds one point for each of several year-on-year signs of improving profitability, lower leverage and better efficiency. Higher is generally stronger.

Based on 8 of the 9 signals — the rest need data not available for this stock.

These are well-known academic screening models, shown for educational context only. They describe historical financial patterns and are not predictions, advice, or a recommendation to buy, sell, or hold.

Key Ratios

Market Cap$2.23B
Current Price$ 17.32
High / Low$ 19.76 / 7.07
Book Value$ 6.01
Dividend Yield0%
ROCE-9.17%
ROE-13.75%
Debt to Equity0.44
Current Ratio4.26
P/B Ratio2.8199282
Debt$341.86M
PAT Margin-14.85%
Cash PAT$-71.95M
ICR-30.88
Educational data only. Not a recommendation to buy, sell or hold any security.